Actively Recruiting
Breast 3DUS ABUS System Comparison
Led by Western University, Canada · Updated on 2025-04-13
30
Participants Needed
1
Research Sites
119 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This comparative study will recruit 30 females who are scheduled for mammography and ultrasound assessment. The clinical 2D ultrasound is performed routinely, and the research portion of this study will add a few extra 3-D ultrasound images during the procedure. The ultrasound imaging laboratory under the direction of Dr. Aaron Fenster has developed a customized device designed to acquire 3D ultrasound of the breast using a commercial ultrasound machine. The purpose is to see how well 3-dimensional ultrasound acquire from that device is able to visualize tumours and other key features in comparison to the clinical system InveniaTM developed by GE Medical.
CONDITIONS
Official Title
Breast 3DUS ABUS System Comparison
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adult patients who are scheduled for screening ABUS
- Adult patients who are scheduled for short term follow-up with ABUS
- Must be at least 18 years of age or older
- Must be proficient in English (reading/writing)
You will not qualify if you...
- Patients with breast implants
- Patients with contraindication for ABUS
- Patients who cannot tolerate ABUS
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
St. Joseph's Hospital
London, Ontario, Canada, N6A 4V2
Actively Recruiting
Research Team
A
Anat Kornecki, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
OTHER
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here